Journal of Leukaemia & Lymphoma Research

Leukaemia In Medicine,extremely Variable,slow-growing Leukaemias,chemotherapy,Leukaemia Open Access,pathology,pediatric Disease,acute Lymphocytic Leukemia,rehabilitation ,cancer Survivors

Leukaemia in medicine: Treatment is extremely variable. The care can require screening for slow-growing leukaemias. Treatment for aggressive leukaemia includes chemotherapy, which is sometimes followed by radiation and stem-cell transplants. Leukaemia Open Access journals are peer-reviewed, open-access journals publishing original research articles, review articles, and clinical studies on all aspects of leukaemia. Leukaemia Open Access may include the detection , diagnosis, epidemiology, pathology, staging, prognosis, leukaemia treatment and prevention, such as drugs, genetics, biomarkers, and the integration of various strategies. Leukemia is the most common pediatric disease. As an increasing number of cancer survivors reach adulthood, the treatment can have consequences, and if low bone mass could be included as a significant late effect, a problem arises. Patients with acute lymphocytic leukemia can get during rehabilitation and for years after its removal, their bone mass has been affected, however the degree of bone mass loss or regeneration is not well elucidated to date. Our aim is to alert about the challenges in measuring and evaluating bone mass in children and teenagers, the shortcomings in this evaluation of young survivors with acute lymphocytic leukemia, the risk of misdiagnosis and the causes (if any) for low bone mass in this specific community of cancer survivors.

High Impact List of Articles

Relevant Topics in Clinical